Our findings indicate that ZNF583 amplification was the primary type of alteration present in cervical cancer patients, while mutational copy number alteration (CNA) and copy number deep deletion were predominant in colorectal cancer and head and neck cancer, respectively (as depicted in Fig. 8C–E). This evidence concerns the gene ZNF583 and cervical carcinoma.